Welcome to our dedicated page for DELIVRA HEALTH BRANDS news (Ticker: DHBUF), a resource for investors and traders seeking the latest updates and insights on DELIVRA HEALTH BRANDS stock.
Delivra Health Brands Inc. (DHBUF) is a consumer packaged goods company based in Vancouver, British Columbia. The company specializes in health and wellness products, offering innovative brands such as Dream Water® and LivRelief™ that address common health issues like sleeplessness, chronic pain, and anxiety. Delivra Health has reported significant growth in revenue and positive year-to-date EBITDA, showcasing a resilient business model. The company is focused on expanding its product portfolio in North America and abroad through strategic marketing activities and new product initiatives.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) reported positive financial results for fiscal 2024, ending June 30, 2024. The company, positioned in the health and wellness sector, saw a 26% year-over-year net revenue growth to $12,378, driven by increased sales in the USA and Canada. Gross profit margin improved to 52% from 49% in the previous year. Adjusted EBITDA increased by 68% to $871K compared to fiscal 2023. The company's portfolio, featuring Dream Water® and LivRelief™ brands, focuses on relief from sleeplessness, chronic pain, and anxiety. CEO Gord Davey emphasized the company's consistent improvement over the past four years and anticipated continued revenue and profitability growth for fiscal 2025.
Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF), a leader in consumer packaged goods in the health and wellness sector, has announced its upcoming annual financial results report for the year ending June 30, 2024. The company will host a conference call on Tuesday, October 8, 2024, at 11:00 a.m. (EST) / 8:00 a.m. (PST) to discuss these results.
The conference call will feature Gord Davey, President and CEO, and Jack Tasse, CFO, who will conduct a Q&A session following management's prepared remarks. Interested parties can join the call by dialing 1-844-763-8274 (Canada/USA Toll Free) or +1-647-484-8814 (International Toll). Participants are advised to dial in 10 minutes before the scheduled start time.
A replay of the call will be available on the company's investor page by the end of the business day on October 8, 2024.
Delivra Health Brands (TSXV: DHB, OTCQB: DHBUF), a leader in the health and wellness sector, has announced the grant of 14,000,000 incentive stock options. This resolution, passed by the Board on May 28, 2024, allows directors, officers, and employees to purchase shares at $0.05 each. These options vest annually over three years and have a five-year term. The initiative aims to align the interests of the company's insiders with its long-term performance and growth strategies.
Delivra Health Brands reported a 36% YoY revenue growth, achieving $8,792K in net revenue for the nine months ending March 31, 2024. The quarterly revenue rose by 31% to $3,071K. The company's adjusted EBITDA improved to $845K from $9K YoY. Gross profit for the nine months was $4,566K, a 61% increase, with a gross margin of 52%, up from 44%. However, total expenses increased by 22% to $3,973K due to marketing initiatives. Quarterly gross profit was $1,540K with a 50% margin. Net loss was $702K for the nine months, compared to $178K last year. The loss per share stood at $0.003 basic and $0.002 diluted. Overall, Delivra Health shows strong revenue growth and improved profitability, despite higher expenses.
FAQ
What is the current stock price of DELIVRA HEALTH BRANDS (DHBUF)?
What is the market cap of DELIVRA HEALTH BRANDS (DHBUF)?
What products does Delivra Health Brands offer?
What are some recent achievements of Delivra Health Brands?
What is the focus of Delivra Health Brands' business model?
What are the core values of Delivra Health Brands?
